Up-Regulation of Cyclooxygenase-2 (COX-2) Expression by Temozolomide (TMZ) in Human Glioblastoma (GBM) Cell Lines

TMZ-resistance remains a main limitation in glioblastoma (GBM) treatment. TMZ is an alkylating agent whose cytotoxicity is modulated by O6-methylguanine-DNA methyltransferase (MGMT), whose expression is determined by MGMT gene promoter methylation status. The inflammatory marker COX-2 has been impli...

Descripción completa

Detalles Bibliográficos
Autores principales: Lombardi, Francesca, Augello, Francesca Rosaria, Artone, Serena, Gugu, Mitilda Karoli, Cifone, Maria Grazia, Cinque, Benedetta, Palumbo, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835858/
https://www.ncbi.nlm.nih.gov/pubmed/35163465
http://dx.doi.org/10.3390/ijms23031545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835858/
https://www.ncbi.nlm.nih.gov/pubmed/35163465
http://dx.doi.org/10.3390/ijms23031545

Ejemplares similares